GAP
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Circular Genomics for the Transformative Bio-Hermes-001 Study
Collaboration to accelerate the investigation of Alzheimer’s disease biomarkers with early access to Bio-Hermes-001 data Washington D.C., May 28, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Circular Genomics, a biotechnology company revolutionizing neurological and psychiatric precision medicine, access to analyze Bio-Hermes-001 samples to investigate the potential for circular RNA […]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership for the Transformative Bio-Hermes-002 Study
Bio-Hermes-002 is a collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer’s disease and dementias. Washington D.C., May 18, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce the continued expansion of the Bio-Hermes-002 study, a unique observational platform study, which evaluates blood-based and digital biomarkers across a wide spectrum of cognitive conditions, alongside MRI and PET imaging and diverse […]
Newsbreak: Experts share updates on memory and aging
Representatives from Butler Hospital’s Memory and Aging Program and the Global Alzheimer’s Platform recently visited the Swansea Council on Aging to discuss normal memory changes with age and new research in Alzheimer’s prevention. The session also encouraged residents to engage with the Acti-v8 initiative and join a prevention registry. This content is adapted from materials provided by Swansea Council On Aging This article includes […]
PR NewsWire: Re:Cognition Health Delivers Landmark International Clinical Trial to Explore Whether a Simple Finger-prick Blood-based Biomarker Test Can Provide Earlier Alzheimer’s Diagnosis
Houston, Texas (April 15, 2026) – Re:Cognition Health, a global leader in new treatments for Alzheimer’s Disease, is delivering an international clinical trial to evaluate whether a simple finger-prick blood test can revolutionize how Alzheimer’s disease is diagnosed. Compared with the current invasive and expensive diagnostic methods, this approach could provide a scalable solution for […]
Clinical Lab Products: Clinical Trial to Evaluate Finger-Prick Blood Test for Alzheimer’s Diagnosis
Apr 17, 2026 | Dementias & Alzheimer’s, Immunoassay | The study will analyze three key proteins to determine if blood-based biomarkers can provide an earlier and more accessible diagnostic method. Re:Cognition Health is delivering an international clinical trial to evaluate whether a finger-prick blood test can improve how Alzheimer’s disease is diagnosed. Compared with current invasive and expensive diagnostic methods, this approach aims […]
Voices of Healthcare: GAP, Siemens Healthineers Partner for Bio-Hermes-002 Alzheimer’s Study
The Global Alzheimer’s Platform Foundation (GAP) has announced a strategic collaboration with Siemens Healthineers for the Bio-Hermes-002 study, an observational platform designed to evaluate biomarkers for Alzheimer’s disease and related dementias. The study compares blood-based and digital biomarkers across a wide range of cognitive conditions, alongside MRI and PET imaging data, to generate insights that […]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Siemens Healthineers for the Transformative Bio-Hermes-002 Study
Siemens Healthineers joins collaborative study focused on new biomarkers designed to improvediagnosis of Alzheimer’s disease and dementias Washington D.C., Apr. 9, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Siemens Healthineers, a leading global medical technology provider pioneering breakthroughs in healthcare, to the Bio-Hermes-002 study. This collaboration will enhance this unique, […]
GAP’s 2026 Q1 Highlights
Colleagues, Trusted Partners, & Friends, We want to share a brief update on how Q1 of 2026 unfolded for the Global Alzheimer’s Platform Foundation (GAP) and the significant work anticipated ahead. In January, our work received global coverage as the British Broadcasting Corporation (BBC) spotlighted the Bio-Hermes-002 (BH2) study in a story about a finger prick blood test […]
Axiom Brain Health’s Dr. Susan Steen to be Honored at Inspire, Imagine, and Hope Gala on Friday
Tampa, FL, Mar 25, 2026— Axiom Brain Health (Axiom) is pleased to announce Dr. Susan Steen will be honored by the Alzheimer’s Association – Florida Gulf Coast Chapter at the Inspire, Imagine, and Hope Gala on Friday, March 27, 2026, at The Gathering @ Armature Works in Tampa. “I am delighted to receive this honor from the […]
Knowridge: A simple blood test could reveal Alzheimer’s early
By Knowridge -March 25, 2026Alzheimer’s disease is one of the most common causes of memory loss in older adults. It slowly affects the brain, making it harder for people to remember things, think clearly, and carry out daily activities. As the global population ages, more and more families are facing the challenges of this condition. Because of […]